Company
United StatesPublic company, NYSE: BLCOBausch and Lomb, Inc (NYSE: BLCO), Bridgewater, NJ – FDA Inspections
Inspection records and compliance data for Bausch and Lomb, Inc in Bridgewater, New Jersey. 1 FDA inspection on record, last inspected May 24, 2024. Publicly traded as NYSE: BLCO.
Company Profile
This profile covers Bausch and Lomb, Inc based in Bridgewater, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected May 24, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 24, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1240407 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bausch and Lomb, Inc
Stock ticker
BLCO
Exchange
NYSE
Share price
$19.96
Market cap
$7.1B
Price as of
November 6, 2026
FEI Number
3030494649
Address
400 Somerset Corporate Blvd, Bridgewater, New Jersey 08807, United States
Country
United States
ID: 2e10c4c9-a3f1-4908-9224-dabc16824d7c